Disclosed is a novel compound acting as a cannabinoid receptor 1 inhibitor, a prodrug thereof, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel compound or the like is useful for preventing or treating diseases mediated by the cannabinoid receptor-1.
公开的是一种作为
大麻素受体1
抑制剂的新化合物,其前体,异构体,其药用可接受盐,
水合物或溶剂化合物。该新化合物或类似物对预防或治疗由
大麻素受体1介导的疾病有用。